Alaunos Therapeutics
TCRT
TCRT
124 hedge funds and large institutions have $90.5M invested in Alaunos Therapeutics in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 21 increasing their positions, 42 reducing their positions, and 42 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
124
Holders Change
-24
Holders Change %
-16.22%
% of All Funds
2.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
21
Increased
21
Reduced
42
Closed
42
Calls
$10.1M
Puts
$491K
Net Calls
+$9.64M
Net Calls Change
+$4.39M
Top Buyers
| 1 |
LCM
1
Laurion Capital Management
New York
|
$5.32M |
| 2 |
2
Millennium Management
New York
|
$2.69M |
| 3 |
3
JPMorgan Chase & Co
New York
|
$5.23M |
| 4 |
E
4
Ergoteles
New York
|
$1.16M |
| 5 |
SGCA
5
Steel Grove Capital Advisors
Memphis,
Tennessee
|
$1.05M |
Top Sellers
| 1 |
1
BlackRock
New York
|
$6.5M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$1.07M |
| 3 |
3
Northern Trust
Chicago,
Illinois
|
$534K |
| 4 |
4
Nuveen Asset Management
Chicago,
Illinois
|
$0 |
| 5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$11.5M |
